We are committed to improving the human condition through discovery and development of novel biopharma technology and therapeutics.
We are a unique biopharma innovation company
We are developing novel therapeutics and technology for a variety of diseases including cancer, immune-inflammation, and other serious disorders. We are also developing a novel chemical synthesis platform for an untapped class of natural products with broad potential in therapeutics and other areas.
We internally fund and advance projects to a significant value point, for example IND ready or proof of concept. This enables us to efficiently develop and offer an advanced opportunity to our downstream partners and investors.
Projects
Immuno-Oncology
Hard-to-treat tumors including melanoma and pancreatic cancer
Inflammation
Acute kidney Injury, COVID-19 injury, pancreatitis and chemotherapy tissue damage
Chemical Synthesis
Biomimetic chemical synthesis project in stealth mode. Contact us or check back for updates